Navigation Links
WuXi PharmaTech Provides Update of 2013 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
Date:1/10/2014

SHANGHAI, Jan. 10, 2014 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development services company, with operations in China and the United States, today announced that it updated its 2013 financial guidance. The company expects to achieve total revenues for full-year 2013 of approximately $578 million. The company expects diluted EPS for full-year 2013 to slightly exceed the top end of its previous guidance of $1.51-$1.55 (GAAP) and $1.73-$1.77 (non-GAAP). These preliminary 2013 results are unaudited and remain subject to the finalization of the company's year-end closing, reporting, and audit processes. The company plans to report its fourth-quarter and full-year 2013 financial results and to provide 2014 financial guidance in March 2014.

The company also announced that it will present at the 32th annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2014 at 8:30 a.m. Pacific Standard Time. The company's slides from the conference will be available on the company's Investor Relations page at www.wuxiapptec.com.

For more information, please contact:

Ronald Aldridge (for investors)
Director, Investor Relations
Tel: +1-201-585-2048
Email: ir@wuxiapptec.com

Aaron Shi (for the media)
Assistant Director, Corporate Communications
Tel: +86-21-5046-4362
Email: pr@wuxiapptec.com

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not historical facts, bu
'/>"/>

SOURCE WuXi PharmaTech
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Winners of WuXi PharmaTech Awards Inducted into Prestigious Academies
2. WuXi PharmaTech Presents 2013 Life Science and Chemistry Awards
3. WuXi PharmaTech to Partner with Pharmacyclics
4. WuXi PharmaTech Announces Third-Quarter 2013 Results
5. WuXi PharmaTech Announces Licensing Agreement for Patient-Derived Xenograft Models with Mayo Clinics Center for Individualized Medicine
6. Zacks.com featured expert Kevin Matras highlights: Core Laboratories NV, Invesco Ltd., Medtronic, Inc., Willbros Group Inc. and WuXi PharmaTech Inc.
7. WuXi PharmaTech Schedules First-Quarter 2013 Earnings Release
8. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
9. WuXi PharmaTech Receives Letter from AAALAC Commending Animal Care at Suzhou Toxicology Facility as "Exemplary"
10. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
11. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... MADISON HEIGHTS, Mich. , March 4, 2015 /PRNewswire/ ... national provider of infusion pumps and related services for ... issue fourth quarter and full year 2014 financial results ... The Company will also conduct a conference ... 4:30 p.m. Eastern Time to discuss fourth quarter and ...
(Date:3/4/2015)... 2015 XBiotech announced today that results ... with moderate to severe plaque psoriasis have been ... trial evaluated the potential benefit of MABp1, the ... alpha (IL-1a). IL-1a is a pro-inflammatory cytokine present ... lesions. The Company claims that blockade of IL-1a ...
(Date:3/4/2015)... 2015 From March 8-11, 2015 Excellis ... Management Conference and Expo in Orlando, ... supply chain education event, attended by nearly 500 ... the pharmaceutical distribution industry moving. Attracting thought-provoking speakers, ... issues important to healthcare distribution and technology, logistics ...
Breaking Medicine Technology:XBiotech Announces Phase II Psoriasis Study Results in JAMA Dermatology 2
... , , ... Inc.,("Chindex") (Nasdaq: CHDX ), a leading independent American provider of ... that the Company will attend the 21st Annual Piper Jaffray,"Unplugged" Health ... the,New York Palace Hotel. , Management is ...
... SAN DIEGO, Nov. 24 Anadys Pharmaceuticals, Inc. (Nasdaq: ... 21st Annual Piper Jaffray Healthcare Conference on Tuesday, December 1, ... conference is being held at The New York Palace Hotel. ... Anadys, will provide an overview of Anadys and its clinical ...
Cached Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2
(Date:3/4/2015)... The Asia-Pacific phthalic anhydride market is estimated to ... at a CAGR of 5.9% during the forecast ... the TOC of Asia-Pacific Phthalic Anhydride Market for ... the help of various tables and figures., ... derivative of phthalic acid, which is either obtained ...
(Date:3/4/2015)... March 04, 2015 Dr. Christopher Asandra, ... Medical Center today lamented the FDA’s recent decision ... (TRT). He argued that FDA’s conclusions are not ... men who suffer from testosterone deficiency. , “The FDA ... on testosterone replacement therapy,” said Dr. Asandra. “There is ...
(Date:3/4/2015)... FDA’s New Inspection Approach:, What Your ... 24, 2015 — 1:30 p.m. – 3:00 p.m. EDT, ... four hours of an inspection whether a manufacturer’s in ... “good” list, they’ll merely ask for reassurance that they ... the “bad” list, the manufacturer must get ready to ...
(Date:3/4/2015)... New York, NY (PRWEB) March 04, 2015 ... highly creative, breakthrough marketing campaign called 'We Love Smokers' ... your cravings for tobacco. , "It’s important to ... and be true to it. Our idea, 'We Love ... provocative, leadership point of view. We created a bold ...
(Date:3/4/2015)... 2015 More than a year after ... associated with low testosterone treatments ( http://www.testosteronelawsuithub.com/ ), the ... will now require manufacturers to warn patients that this ... attacks and strokes. In a Drug Safety Communication ... that it was requiring testosterone manufacturers to update the ...
Breaking Medicine News(10 mins):Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 2Health News:The Asia-Pacific Ohthalic Anhydride Market is Estimated to Reach $5,632.8 Million by 2019 - A Report by MicroMarket Monitor 3Health News:NuMale’s Dr. Christopher Asandra: FDA Suffering from “Premature Equivocation” on Issue of Testosterone and Risks 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 2Health News:The Brand Behind The Bold and Provocative Ad Campaign 'We Love Smokers' 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 3Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Comment on FDA Mandate For New Cardiovascular Warnings on Low T Therapy Drugs 4
... New DICOM solutions can connect Q-Stress and Q-Tel ... 30 Cardiac Science (Nasdaq: CSCX ... resuscitation, rehabilitation, and informatics products, today added DICOM ... system and Quinton Q-Tel cardiac rehabilitation system. "With ...
... over 40 years, Dr. Kachmann teaches how the ... for optimum health.FORT WAYNE, Ind., March 30 ... M.D., creator of the Kachmann Mind Body Institute ... teacher, is synonymous with health and the arts. ...
... an employment Web site dedicated to helping employers in the ... for their businesses to thrive. , ... ... Inc., a leading creator of highly interactive, online community-based news ...
... 2009) As childhood obesity continues its thirty-year advance from ... to find out whyand the reasons are many. Increasingly sedentary ... and ubiquitous processed foods no doubt play a role, but ... childhood obesity may begin as far back as early infancy. ...
... Soldiers who survive severe injuries on battlefields such as ... from developing infections of their wounds with multidrug resistant ... methicillin resistant Staphylococcus aureus (MRSA), Acinetobacter ... and Escherichia coli . , Dr Clinton K. Murray, ...
... such as first-person-shooter games, increase a player,s real-world vision, ... , The ability to discern slight differences in shades ... attribute of the human visual system that cannot be ... sciences at the University of Rochester, has discovered that ...
Cached Medicine News:Health News:Cardiac Science Connects to EMR, HIS, PACS Systems Using DICOM and HL7 Technologies 2Health News:Cardiac Science Connects to EMR, HIS, PACS Systems Using DICOM and HL7 Technologies 3Health News:Cardiac Science Connects to EMR, HIS, PACS Systems Using DICOM and HL7 Technologies 4Health News:Dr. Rudy Kachmann, Neurosurgeon, Author, Lecturer & Founder of Kachmann Mind Body Institute Selects TransMedia Group as Agency of Record 2Health News:Advance Internet Launches HireBioMedical.com 2Health News:Infant weight gain linked to childhood obesity 2Health News:Infant weight gain linked to childhood obesity 3Health News:Action video games improve vision 2
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
Algerbrush II corneal rust ring remover battery powered...
... complex grinding formula to produce ... are specifically manufactured to display ... as the lenses used in ... Marco custom trial lens set ...
Khosla Mini Non-Illuminated Trial Lens Set, With Lenses Mounted...
Medicine Products: